Omnicell, Inc. (OMCL) Fair Value 2026

OMCL · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.5 /10

32 fundamental signals · 10 models active

Value Trap Risk

LOW (25/100)

Quick Summary — As of 2026-10-07, Omnicell, Inc. (OMCL) trades at $35.46, versus a $28.68 median fair value across its 10 active models — 19.1% below the current price. QOC: 7.5/10. Value Trap Risk: 25/100 (LOW). 10/13 models active. Within that set, the Bayesian DCF component alone returns $31.33.

Key Facts

Ticker
OMCL
Price
$35.46
Quality Score
7.5/10
Value Trap Risk
25/100
Models Active
10/13
Last Updated
Strength: 10 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Omnicell, Inc. (OMCL) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Omnicell, Inc. (OMCL) appears overvalued as of : the median of 10 independent fair value estimates is $28.68, 19.1% below the current price of $35.46. Estimates range from $4.98 to $71.98. OMCL scores 7.5/10 on fundamental quality and 25/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. OMCL’s -19.1% gap is narrower than that market norm, and the Health Information Services sector median is +1.2%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Omnicell, Inc. Stock in 2026? →

What Fair Value Does Each Model Give OMCL?

10 Intrinsic Value Models vs. Current Price ($35.46)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $31.33 -11.6%
Intrinsic · High Conviction
 $4.98 -85.9%
Ensemble · Low Conviction
 $26.04 -26.6%
Intrinsic · High Conviction
 $19.00 -46.4%
Unlock the Full Matrix

Access 6 additional models including Markov DDM, ML-RIV, and more.

$2 / day

Billed monthly ($60/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is OMCL's Fair Value Range?

Spread across 10 independent models · $4.98 to $71.98

CirclFi's 10 active models place Omnicell, Inc. (OMCL) between $4.98 and $71.98 per share, a spread of 234% of the median. The median of that range — $28.68 — is the fair value CirclFi publishes for OMCL, against a current price of $35.46.

Low · EPVHigh · Regime Cross
$4.98median $28.68$71.98
Where the range comes from
Most bearish modelEarnings Power Value (EPV)$4.98
Most bullish modelRegime Cross-Sectional$71.98
Model agreement2 bullish · 6 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for OMCL. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on OMCL, not a CirclFi price target. How each model works →

What Is Omnicell, Inc. (OMCL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Omnicell, Inc. at its current price of $35.46. The median intrinsic value is estimated at $28.68 (-19.1% vs price), with 6 models flagging overvaluation risk. Model dispersion is worth noting: Regime Cross targets $71.98 (+103.0%), versus EPV at $4.98 (-85.9%). This +188.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About OMCL?

10 of 13 models are currently active for OMCL. Of these, 3 models suggest upside while 7 models suggest overvaluation. Taken together, their median fair value for OMCL is $28.68 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $31.33 on its own, implying -11.6% downside from the current price. See which stocks rank higher →

How Does OMCL Rank in Health Information Services?

Among 53 Health Information Services stocks, OMCL ranks #14 by Quality of Company score. CirclFi's QOC score of 7.5/10 evaluates 32 fundamental signals. A score of 7.5 indicates above-average quality.

See all Most Undervalued Health Information Services Stocks →

Omnicell, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is OMCL a Value Trap?

CirclFi's Value Trap algorithm assigns OMCL a score of 25/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Omnicell, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Omnicell, Inc.'s fundamental quality profile registers 7.5/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +188.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every OMCL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across OMCL's 10 active models, average confidence is 46%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Omnicell, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

CERTCertara, Inc.QOC 7.5LFMDLifeMD, Inc.QOC 7.5WAYWaystar Holding Corp.QOC 7.7SLPSimulations Plus, Inc.QOC 7.4PRVAPrivia Health Group, Inc.QOC 8.0TDOCTeladoc Health, Inc.QOC 7.3CARLCarlsmed, Inc.QOC 6.3MGRXMangoceuticals, Inc.QOC 4.9ZCMDZhongchao Inc.QOC 1.7DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: CERT · LFMD · WAY · SLP · PRVA · TDOC · CARL · MGRX · ZCMD · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to OMCL?

7 companies across all industries closest to OMCL’s Quality of Company score of 7.5/10.

MICCThe Magnum Ice Cream Company N.V.QOC 7.5PFEPfizer Inc.QOC 7.5JAKKJAKKS Pacific, Inc.QOC 7.5AMRCAmeresco, Inc.QOC 7.5IMMRImmersion CorporationQOC 7.5ICUIICU Medical, Inc.QOC 7.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: MICC · PFE · JAKK · AMRC · IMMR · ICUI · NVDA

Where Does OMCL Sit in CirclFi's Health Information Services Rankings?

OMCL is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About Omnicell, Inc.’s Valuation?

What is Omnicell, Inc.'s intrinsic value in 2026?

CirclFi puts Omnicell, Inc. (OMCL)'s intrinsic value at $28.68 — the median of 10 independent model estimates as of 2026-10-07, ranging from $4.98 to $71.98. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $31.33 on its own. The Quality of Company score is 7.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is OMCL overvalued or undervalued right now?

At $35.46, 3 of 10 active models suggest OMCL may be undervalued, while 7 indicate potential overvaluation. The median of all 10 fair value estimates is $28.68, 19.1% below the current price of $35.46 — a consensus view that OMCL is overvalued. The assessment depends on which methodology best fits Omnicell, Inc.'s business model in Health Information Services.

What does a Quality of Company score of 7.5 mean for OMCL?

Omnicell, Inc.'s QOC of 7.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on OMCL?

CirclFi analyzes OMCL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on OMCL?

Of the 10 models currently active on OMCL, Regime Cross-Sectional is the most bullish at $71.98 per share, and Earnings Power Value (EPV) is the most bearish at $4.98. CirclFi's published fair value for OMCL is the median of that range, $28.68, not either extreme. The gap between the two ends equals 234% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is OMCL a value trap in 2026?

Omnicell, Inc.'s Value Trap score is 25/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Omnicell, Inc. (OMCL) has a median fair value of $28.68 — 19.1% below the current price of $35.46 — as of 2026-10-07.” Source: circlfi.com/stock/OMCL/ · Methodology
Primary sources for this OMCL valuation
  • Financial statements: Omnicell, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000926326) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for OMCL as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on OMCL.

Unlock All 10 Fair Values — $60/mo

Cancel anytime · Less than a cup of coffee · Instant access

6 models hidden for OMCL Unlock All 10 — $60/mo